Cellavision AB 

$9.04
9
+$0.29+3.31% Monday 20:00

Statistics

Day High
8.75
Day Low
8.75
52W High
9.04
52W Low
8.75
Volume
100
Avg. Volume
202
Mkt Cap
215.62M
P/E Ratio
-
Dividend Yield
1.69%
Dividend
0.15

Upcoming

Earnings

24AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
1.08
1.33
1.59
1.85
Expected EPS
1.57368091883457
Actual EPS
N/A

Financials

19.45%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
131.24MRevenue
25.53MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CVLLY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories offers digital imaging systems in clinical diagnostics, competing in the digital cell morphology space with Cellavision.
Danaher
DHR
Mkt Cap152.13B
Danaher, through its subsidiaries like Beckman Coulter, provides hematology analyzers and related laboratory equipment, directly competing with Cellavision's digital microscopy and image analysis technologies.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation offers microscopy and diagnostic solutions that overlap with Cellavision's digital cell imaging and analysis market.
Hologic
HOLX
Mkt Cap16.45B
Hologic provides diagnostic products and digital imaging systems that serve similar markets as Cellavision, particularly in cytology and pathology.
Agilon Health
AGL
Mkt Cap330.09M
Agilent Technologies offers a range of analytical instruments, including cell analysis solutions that compete with Cellavision's digital microscopy in the life sciences and diagnostics sectors.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a broad range of analytical and diagnostic equipment, including cell imaging systems that compete with Cellavision's offerings.
Resmed
RMD
Mkt Cap36.04B
ResMed, while primarily focused on sleep and respiratory markets, has ventured into health informatics and diagnostic software that could indirectly compete with Cellavision's digital analysis tools.
Illumina
ILMN
Mkt Cap18.99B
Illumina, known for its genetic variation and function systems, also offers imaging and analysis solutions that could compete with Cellavision in genomics and pathology markets.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health, primarily focused on liquid biopsy, also develops digital and analytical tools for cancer diagnostics, potentially competing with Cellavision's imaging and analysis technologies.

About

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 for performing blood cell differentials; and CellaVision DM1200 and CellaVision DM9600 to automate and simplify the process of performing blood and body fluid differentials. In addition, the company's CellaVision Peripheral Blood Application enables laboratories to automate, standardize and simplify morphological examination like peripheral blood smears; CellaVision Advanced RBC Application performs a more comprehensive examination for red blood cell morphology; CellaVision Body Fluid Application is for examination body fluid preparations; CellaVision CellAtlas is an app with morphology experts for series mini lectures on extensive cell image library introduction to cell morphology; CellaVision Remote Review Software removes restrictive geographical constraints from smear review process and performs better; CellaVision Server Software creates a single streamlined workflow within one or multiple testing sites; and CellaVision VET is a veterinary lab. It sells its products to hospitals and commercial laboratories. The company was incorporated in 1994 and is based in Lund, Sweden.
Show more...
CEO
Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.
Employees
229
Country
SE
ISIN
US15118A1043

Listings

0 Comments

Share your thoughts

FAQ

What is Cellavision AB stock price today?
The current price of CVLLY is $9.04 USD — it has increased by +3.31% in the past 24 hours. Watch Cellavision AB stock price performance more closely on the chart.
What is Cellavision AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cellavision AB stocks are traded under the ticker CVLLY.
What is Cellavision AB market cap?
Today Cellavision AB has the market capitalization of 215.62M
When is the next Cellavision AB earnings date?
Cellavision AB is going to release the next earnings report on April 24, 2026.
What were Cellavision AB earnings last quarter?
CVLLY earnings for the last quarter are 0.19 USD per share, whereas the estimation was 0.14 USD resulting in a +37.28% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cellavision AB revenue for the last year?
Cellavision AB revenue for the last year amounts to 131.24M USD.
What is Cellavision AB net income for the last year?
CVLLY net income for the last year is 25.53M USD.
How many employees does Cellavision AB have?
As of April 01, 2026, the company has 229 employees.
In which sector is Cellavision AB located?
Cellavision AB operates in the Industrials sector.
When did Cellavision AB complete a stock split?
Cellavision AB has not had any recent stock splits.
Where is Cellavision AB headquartered?
Cellavision AB is headquartered in Lund, SE.